Return to content in this issue

 

Association Between Component-Resolved Diagnosis of House Dust Mite Allergy and Efficacy and Safety of Specific Immunotherapy

Arroabarren E1, Echechipía S1, Galbete A2, Lizaso MT1, Olaguibel JM1,3, Tabar AI1,4,5

1Servicio de Alergologia, Complejo Hospitalario de Navarra, Pamplona, Spain
2Navarrabiomed- Centro Hospitalario de Navarra-UPNA, Pamplona, Spain
3CIBER Respiratorio
4Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
5RETIC de Asma, Reacciones adversas y Alérgicas (ARADYAL)

J Investig Allergol Clin Immunol 2019; Vol 29(2) : 164-167
doi: 10.18176/jiaci.0359

Key words: Allergen immunotherapy, House dust mite, Component resolved diagnosis (CRD), Efficacy, Major allergens